MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gastroesophageal dysmotility in advanced Parkinson’s Disease

F. Mancini, M. Lacerenza, L. Manfredi, A. Bestetti (Milan, Italy)

Meeting: 2017 International Congress

Abstract Number: 88

Keywords: Gastrointestinal problemsm(also see autonomic dysfunction)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The aim of this study is to evaluate the patterns of gastroparesis in PD patients with motor fluctuations and dyskinesias.

Background: Gastrointestinal dysfunction is the most common non-motor symptom of Parkinson’s disease (PD), and has been often attributed to gastroparesis. In PD patients, gastroparesis has the potential to affect the absorption of medications and, consequently, motor function. 

Methods: Scintigraphy with radiolabeled sulfur colloid added to acidified orange juice was performed in 85 consecutive advanced PD patients 1 hour after their usual dopaminergic therapy first dose in the morning, to evaluate, among others data, the gastric emptying half time T1/2 (GE). Clinical evaluations at scintigraphy time consisted of collection of demographic, neurological, gastrointestinal and pharmacological data. 

Results: The 85 patients (32 women, mean age: 68 ± 9,2 years, mean disease duration: 10 ± 6,2 years, mean UPDRS III in ON: 17 ± 12,6,median H&Y 3) were divided into 2 groups, using the cut-off point of 40 minutes obtained in normal subjects. The subgroup 1 consisted of 44 patients (69 ± 9.1 years) with GE T1/2 of 26,6 ± 6,9 minutes (normal), the subgroup 2 (65.7 ± 10.2 years) showed a GE of 88.7 ± 58 minutes (delayed). There were no significant differences in demographic or clinical parameters between patients of two groups. Linear regression showed a significant correlation between GE and dosage of peripheral inhibitors, dopamine-agonist dosage and of plasmatic dopamine level (P< 0,05).

Conclusions: This observational study outlines that delayed GE is present in approximately 50% of PD patients with motor fluctuations (delayed-on, wearing off, on-off, no-on) and dyskinesias. The dosage of peripheral inhibitors may concur in GE delay and its consequent effect on drug delivery and efficacy.

References: Bestetti A1, Carola F, Carnevali-Ricci P, Sambataro G, Tarolo GL. 99mTc-sulfur colloid gastroesophageal scintigraphy with late lung imaging to evaluate patients with posterior laryngitis. J Nucl Med. 2000 Oct;41(10):1597-602.

Heetun ZS, Quigley EM. Gastroparesis and Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2012 Jun;18(5):433-40. doi: 10.1016/j.parkreldis.2011.12.004. 

To cite this abstract in AMA style:

F. Mancini, M. Lacerenza, L. Manfredi, A. Bestetti. Gastroesophageal dysmotility in advanced Parkinson’s Disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/gastroesophageal-dysmotility-in-advanced-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gastroesophageal-dysmotility-in-advanced-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley